Remacemide
Remacemide is a drug. It has been studied for the treatment of acute ischemic stroke, epilepsy, Huntington's disease, and Parkinson's disease. Reference standards of Remacemide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Remacemide - API Standards
[catalogue_number] => PA 18 1150000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[weight] => 268.36
[form] => C17H20N2O
[cas] => 128298-28-2
[pslug] => 128298-28-2-remacemide-api-pa181150000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Remacemide - API Standards
Catalogue No.:PA 18 1150000
Molecular Formula : C17H20N2O
Molecular Weight : 268.36